Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Variations in arterial pedal circulation in idiopathic congenital talipes equinovarus: a systematic review.

Puri AMC, Hughes KP, Stenson KM, Gelfer Y, Holt PJE, Patterson BO.

J Pediatr Orthop B. 2020 Mar 16. doi: 10.1097/BPB.0000000000000724. [Epub ahead of print]

PMID:
32195760
2.

Recommendations for management of infected aortic pathology based on current evidence.

Stenson KM, Grima MJ, Loftus IM, Tripathi RK.

Semin Vasc Surg. 2019 Mar - Jun;32(1-2):68-72. doi: 10.1053/j.semvascsurg.2019.07.003. Epub 2019 Jul 24.

PMID:
31540659
3.

Migration and sac expansion as modes of midterm therapeutic failure after endovascular aneurysm sealing.

Stenson KM, de Bruin JL, Loftus IM, Holt PJE.

J Vasc Surg. 2020 Feb;71(2):457-469.e1. doi: 10.1016/j.jvs.2019.04.482. Epub 2019 Aug 9.

PMID:
31405762
4.

Association of Perioperative Opioid-Sparing Multimodal Analgesia With Narcotic Use and Pain Control After Head and Neck Free Flap Reconstruction.

Eggerstedt M, Stenson KM, Ramirez EA, Kuhar HN, Jandali DB, Vaughan D, Al-Khudari S, Smith RM, Revenaugh PC.

JAMA Facial Plast Surg. 2019 Sep 1;21(5):446-451. doi: 10.1001/jamafacial.2019.0612.

PMID:
31393513
5.

Enhanced recovery after surgery in head and neck surgery: Reduced opioid use and length of stay.

Jandali DB, Vaughan D, Eggerstedt M, Ganti A, Scheltens H, Ramirez EA, Revenaugh PC, Al-Khudari S, Smith RM, Stenson KM.

Laryngoscope. 2019 Jul 17. doi: 10.1002/lary.28191. [Epub ahead of print]

PMID:
31314144
6.

Short Stay EVAR is Safe and Cost Effective.

Shaw SE, Preece R, Stenson KM, De Bruin JL, Loftus IM, Holt PJE, Patterson BO.

Eur J Vasc Endovasc Surg. 2019 Mar;57(3):368-373. doi: 10.1016/j.ejvs.2018.10.008. Epub 2018 Nov 12.

7.

Commentary: Outcomes of Endovascular Aneurysm Sealing According to the Revised Nellix Instructions for Use: The Impact on Complications Is Not Yet Apparent.

Stenson KM, Holt PJE.

J Endovasc Ther. 2018 Aug;25(4):426-427. doi: 10.1177/1526602818784028. Epub 2018 Jun 25. No abstract available.

PMID:
29936887
8.

Midterm results of endovascular aneurysm sealing to treat abdominal aortic aneurysm.

Stenson KM, Patterson BO, Grima MJ, De Bruin JL, Holt PJE, Loftus I.

J Vasc Surg. 2019 Jan;69(1):53-62.e1. doi: 10.1016/j.jvs.2018.04.016. Epub 2018 May 24.

PMID:
29804737
9.

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience.

Foster CC, Melotek JM, Brisson RJ, Seiwert TY, Cohen EEW, Stenson KM, Blair EA, Portugal L, Gooi Z, Agrawal N, Vokes EE, Haraf DJ.

Oral Oncol. 2018 May;80:16-22. doi: 10.1016/j.oraloncology.2018.03.008. Epub 2018 Mar 16.

PMID:
29706184
10.

Extended use of endovascular aneurysm sealing: Chimneys for juxtarenal aneurysms.

Stenson KM, De Bruin JL, Holt PJ, Loftus IM, Thompson MM.

Semin Vasc Surg. 2016 Sep;29(3):120-125. doi: 10.1053/j.semvascsurg.2016.11.006. Epub 2016 Nov 5. Review.

PMID:
27989317
11.

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.

Seiwert TY, Melotek JM, Blair EA, Stenson KM, Salama JK, Witt ME, Brisson RJ, Chawla A, Dekker A, Lingen MW, Kocherginsky M, Villaflor VM, Cohen EE, Haraf DJ, Vokes EE.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):21-9. doi: 10.1016/j.ijrobp.2016.04.030. Epub 2016 May 7.

PMID:
27511844
12.

Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer.

Villaflor VM, Melotek JM, Karrison TG, Brisson RJ, Blair EA, Portugal L, De Souza JA, Ginat DT, Stenson KM, Langerman A, Kocherginsky M, Spiotto MT, Hannigan N, Seiwert TY, Cohen EE, Vokes EE, Haraf DJ.

Ann Oncol. 2016 May;27(5):908-13. doi: 10.1093/annonc/mdw051. Epub 2016 Feb 15.

13.

Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.

Golden DW, Rudra S, Witt ME, Nwizu T, Cohen EE, Blair E, Stenson KM, Vokes EE, Haraf DJ.

Oral Oncol. 2013 Mar;49(3):277-82. doi: 10.1016/j.oraloncology.2012.10.003. Epub 2012 Oct 25.

PMID:
23102863
14.

Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.

Mouw KW, Solanki AA, Stenson KM, Witt ME, Blair EA, Cohen EEW, Vokes EE, List M, Haraf DJ, Salama JK.

Oral Oncol. 2012 Oct;48(10):1025-1030. doi: 10.1016/j.oraloncology.2012.04.004. Epub 2012 May 22.

PMID:
22621836
15.

A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck.

de Souza JA, Davis DW, Zhang Y, Khattri A, Seiwert TY, Aktolga S, Wong SJ, Kozloff MF, Nattam S, Lingen MW, Kunnavakkam R, Stenson KM, Blair EA, Bozeman J, Dancey JE, Vokes EE, Cohen EE.

Clin Cancer Res. 2012 Apr 15;18(8):2336-43. doi: 10.1158/1078-0432.CCR-11-2825. Epub 2012 Feb 27.

16.

Chemoradiation for patients with large-volume laryngeal cancers.

Stenson KM, Maccracken E, Kunnavakkam R, W Cohen EE, Portugal LD, Villaflor V, Seiwert T, Blair E, Haraf DJ, Salama JK, Vokes EE.

Head Neck. 2012 Aug;34(8):1162-7. doi: 10.1002/hed.21888. Epub 2011 Nov 3.

PMID:
22052816
17.

Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.

Pederson AW, Salama JK, Haraf DJ, Witt ME, Stenson KM, Portugal L, Seiwert T, Villaflor VM, Cohen EE, Vokes EE, Blair EA.

Head Neck Oncol. 2011 Jul 26;3:31. doi: 10.1186/1758-3284-3-31.

18.

The use of bone wax for protection from sharp ends of interdental wires.

Pilanci O, Stenson KM, Kuvat SV.

Indian J Plast Surg. 2011 Jan;44(1):160. doi: 10.4103/0970-0358.81462. No abstract available.

19.

Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.

Choe KS, Haraf DJ, Solanki A, Cohen EE, Seiwert TY, Stenson KM, Blair EA, Portugal L, Villaflor VM, Witt ME, Vokes EE, Salama JK.

Cancer. 2011 Oct 15;117(20):4671-8. doi: 10.1002/cncr.26084. Epub 2011 Jun 13.

20.

Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.

Pederson AW, Salama JK, Witt ME, Stenson KM, Blair EA, Vokes EE, Haraf DJ.

Am J Clin Oncol. 2011 Aug;34(4):356-61. doi: 10.1097/COC.0b013e3181e8420b.

PMID:
21633289
21.

The value of intraoperative ultrasound and preoperative imaging, individually and in combination, in liver resection for metastatic colorectal cancer.

Lordan JT, Stenson KM, Karanjia ND.

Ann R Coll Surg Engl. 2011 Apr;93(3):246-9. doi: 10.1308/147870811X566376.

22.

Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.

Villaflor VM, Haraf D, Salama JK, Kocherginsky M, Langerman A, Gomez-Abuin G, Beniwal P, Blair EA, Stenson KM, Portugal L, Seiwert T, Williams RD, Dekker AJ, Witt ME, Vokes EE, Cohen EE.

Ann Oncol. 2011 Nov;22(11):2501-7. doi: 10.1093/annonc/mdq785. Epub 2011 Mar 8.

23.

Airway management before chemoradiation for advanced head and neck cancer.

Langerman A, Patel RM, Cohen EE, Blair EA, Stenson KM.

Head Neck. 2012 Feb;34(2):254-9. doi: 10.1002/hed.21729. Epub 2011 Mar 7.

PMID:
21384461
24.

A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.

Salama JK, Haraf DJ, Stenson KM, Blair EA, Witt ME, Williams R, Kunnavakkam R, Cohen EE, Seiwert T, Vokes EE.

Ann Oncol. 2011 Oct;22(10):2304-9. doi: 10.1093/annonc/mdq736. Epub 2011 Feb 17.

25.

Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.

Mouw KW, Haraf DJ, Stenson KM, Cohen EE, Xi X, Witt ME, List M, Blair EA, Vokes EE, Salama JK.

Arch Otolaryngol Head Neck Surg. 2010 Dec;136(12):1226-34. doi: 10.1001/archoto.2010.218.

PMID:
21173372
26.

Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.

Choe KS, Salama JK, Stenson KM, Blair EA, Witt ME, Cohen EE, Haraf DJ, Vokes EE.

Radiother Oncol. 2010 Nov;97(2):318-21. doi: 10.1016/j.radonc.2010.09.003. Epub 2010 Oct 9.

PMID:
20934766
27.

Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.

Cohen EE, Haraf DJ, Kunnavakkam R, Stenson KM, Blair EA, Brockstein B, Lester EP, Salama JK, Dekker A, Williams R, Witt ME, Grushko TA, Dignam JJ, Lingen MW, Olopade OI, Vokes EE.

J Clin Oncol. 2010 Jul 10;28(20):3336-43. doi: 10.1200/JCO.2009.27.0397. Epub 2010 May 24.

28.

Retrograde endoscopic-assisted esophageal dilation.

Langerman A, Stenson KM, Ferguson MK.

J Gastrointest Surg. 2010 Jul;14(7):1186-9. doi: 10.1007/s11605-010-1205-z. Epub 2010 May 4.

PMID:
20440656
29.

Chemoreirradiation for recurrent salivary gland malignancies.

Pederson AW, Haraf DJ, Blair EA, Stenson KM, Witt ME, Vokes EE, Salama JK.

Radiother Oncol. 2010 Jun;95(3):308-11. doi: 10.1016/j.radonc.2010.03.006. Epub 2010 Apr 10.

PMID:
20385414
30.

Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.

Pederson AW, Haraf DJ, Witt ME, Stenson KM, Vokes EE, Blair EA, Salama JK.

Head Neck. 2010 Nov;32(11):1519-27. doi: 10.1002/hed.21360.

PMID:
20187015
31.

Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer.

Langerman A, Plein C, Vokes EE, Salama JK, Haraf DJ, Blair EA, Stenson KM.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1133-6. doi: 10.1001/archoto.2009.154.

PMID:
19917927
32.

Chemoradiation for patients with advanced oral cavity cancer.

Stenson KM, Kunnavakkam R, Cohen EE, Portugal LD, Blair E, Haraf DJ, Salama J, Vokes EE.

Laryngoscope. 2010 Jan;120(1):93-9. doi: 10.1002/lary.20716.

PMID:
19856305
33.

Neck dissection planning based on postchemoradiation computed tomography in patients with head and neck cancer.

Langerman A, Comstock R, Konda S, Abramovitch A, Kasza K, Vokes EE, Stenson KM.

Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):876-80. doi: 10.1001/archoto.2009.119.

PMID:
19770419
34.

Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.

Salama JK, Stenson KM, List MA, Mell LK, Maccracken E, Cohen EE, Blair E, Vokes EE, Haraf DJ.

Arch Otolaryngol Head Neck Surg. 2008 Oct;134(10):1060-5. doi: 10.1001/archotol.134.10.1060.

PMID:
18936351
35.

Free-flap reconstruction in the doubly irradiated patient population.

Cohn AB, Lang PO, Agarwal JP, Peng SL, Alizadeh K, Stenson KM, Haraf DJ, Cohen EE, Vokes EE, Gottlieb LJ.

Plast Reconstr Surg. 2008 Jul;122(1):125-32. doi: 10.1097/PRS.0b013e3181773d39.

PMID:
18594395
36.

Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.

Salama JK, Stenson KM, Kistner EO, Mittal BB, Argiris A, Witt ME, Rosen F, Brockstein BE, Cohen EE, Haraf DJ, Vokes EE.

Ann Oncol. 2008 Oct;19(10):1787-94. doi: 10.1093/annonc/mdn364. Epub 2008 Jun 6.

37.

Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.

Knab BR, Salama JK, Solanki A, Stenson KM, Cohen EE, Witt ME, Haraf DJ, Vokes EE.

Ann Oncol. 2008 Sep;19(9):1650-4. doi: 10.1093/annonc/mdn173. Epub 2008 May 7.

38.

The thoracoacromial trunk: alternative recipient vessels in reoperative head and neck reconstructive microsurgery.

Aycock JK, Stenson KM, Gottlieb LJ.

Plast Reconstr Surg. 2008 Jan;121(1):88-94. doi: 10.1097/01.prs.0000293858.11494.96.

PMID:
18176209
39.

Aspiration in chemoradiated patients with head and neck cancer.

Langerman A, Maccracken E, Kasza K, Haraf DJ, Vokes EE, Stenson KM.

Arch Otolaryngol Head Neck Surg. 2007 Dec;133(12):1289-95.

PMID:
18086974
40.

High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.

Cohen EE, Haraf DJ, List MA, Kocherginsky M, Mittal BB, Rosen F, Brockstein B, Williams R, Witt ME, Stenson KM, Kies MS, Vokes EE.

J Clin Oncol. 2006 Jul 20;24(21):3438-44.

41.

Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.

Milano MT, Vokes EE, Kao J, Jackson W, List MA, Stenson KM, Witt ME, Dekker A, MacCracken E, Garofalo MC, Chmura SJ, Weichselbaum RR, Haraf DJ.

Int J Oncol. 2006 May;28(5):1141-51.

PMID:
16596230
42.

Planned post-chemoradiation neck dissection: significance of radiation dose.

Stenson KM, Huo D, Blair E, Cohen EE, Argiris A, Haraf DJ, Vokes EE.

Laryngoscope. 2006 Jan;116(1):33-6.

PMID:
16481805
43.
44.

Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.

Salama JK, Vokes EE, Chmura SJ, Milano MT, Kao J, Stenson KM, Witt ME, Haraf DJ.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):382-91. Epub 2005 Oct 5.

PMID:
16213104
45.

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.

Milano MT, Vokes EE, Salama JK, Stenson KM, Kao J, Witt ME, Mittal BB, Argiris A, Weichselbaum RR, Haraf DJ.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1096-106.

PMID:
15752889
46.

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.

Milano MT, Haraf DJ, Stenson KM, Witt ME, Eng C, Mittal BB, Argiris A, Pelzer H, Kozloff MF, Vokes EE.

Clin Cancer Res. 2004 Aug 1;10(15):4922-32.

47.

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.

Brockstein B, Haraf DJ, Rademaker AW, Kies MS, Stenson KM, Rosen F, Mittal BB, Pelzer H, Fung BB, Witt ME, Wenig B, Portugal L, Weichselbaum RW, Vokes EE.

Ann Oncol. 2004 Aug;15(8):1179-86.

48.

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.

Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE.

Head Neck. 2004 May;26(5):447-55.

PMID:
15122662
49.

Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.

Argiris A, Brockstein BE, Haraf DJ, Stenson KM, Mittal BB, Kies MS, Rosen FR, Jovanovic B, Vokes EE.

Clin Cancer Res. 2004 Mar 15;10(6):1956-62.

50.

Therapeutic options for laryngeal cancer.

Vokes EE, Stenson KM.

N Engl J Med. 2003 Nov 27;349(22):2087-9. No abstract available.

PMID:
14645634

Supplemental Content

Loading ...
Support Center